Tofacitinib for the Treatment of Psoriasis and Psoriatic Arthritis

Expert Review of Clinical Immunology - United Kingdom
doi 10.1080/1744666x.2018.1512404
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2017English

IMPROVE: Mortality in Psoriasis and Psoriatic Arthritis

British Journal of Dermatology
DermatologyMedicine
2019English

Clinical Experience of Cyclosporin Treatment in Patients With Psoriasis and Psoriatic Arthritis

Journal of Dermatology
DermatologyMedicine
2017English

Benefits vs. Side Effects of Adalimumab Treatment in Psoriasis/Psoriatic Arthritis

The Journal of Medical Research
2017English

Ixekizumab: Targeting Plaque Psoriasis and Psoriatic Arthritis

Prescriber
Pharmacology
2019English

Which Psoriasis Patients Develop Psoriatic Arthritis?

Psoriasis Forum
2010English

The Pathological Role of Wnt5a in Psoriasis and Psoriatic Arthritis

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

SAT0439 Integrated Safety Summary of Tofacitinib in Psoriatic Arthritis Clinical Studies

2017English

Risk of Diabetes Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy